Moderna cuts sales numbers

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Moderna cut its 2025 sales forecast by $1 billion due to slow RSV shot adoption and weak COVID-19 vaccine demand, causing shares to drop over 20%.

Actual Topics